Country: United Kingdom
Language: English
Source: MHRA (Medicines & Healthcare Products Regulatory Agency)
Prednisolone sodium phosphate
Focus Pharmaceuticals Ltd
H02AB06
Prednisolone sodium phosphate
5mg
Soluble tablet
Oral
No Controlled Drug Status
Valid as a prescribable product
BNF: 06030200; GTIN: 5060064792414
170 mm 10 mm 10 mm 375 mm 170 mm 375 mm PACKAGE LEAFLET: INFORMATION FOR THE USER PREDNISOLONE 5MG SOLUBLE TABLETS prednisolone READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. • Keep this leaflet. You may need to read it again. • If you have any further questions, ask your doctor, pharmacist or nurse. • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. • If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET 1. What Prednisolone Soluble Tablets are and what they are used for 2. What you need to know before you take Prednisolone Soluble Tablets 3. How to take Prednisolone Soluble Tablets 4. Possible side effects 5. How to store Prednisolone Soluble Tablets 6. Contents of the pack and other information 1. WHAT PREDNISOLONE SOLUBLE TABLETS ARE AND WHAT THEY ARE USED FOR Your doctor has decided that you or your child, need this medicine to help treat your or their, condition. Prednisolone 5mg Soluble Tablets (called Prednisolone Soluble Tablets throughout the rest of this leaflet) contain the active ingredient prednisolone. Prednisolone belongs to a group of medicines called steroids (the full name is corticosteroids). Corticosteroids occur naturally in the body and help to maintain health and wellbeing. Boosting your body with extra corticosteroid (such as prednisolone) is an effective way to treat various illnesses involving inflammation in the body. Prednisolone Soluble Tablets reduce this inflammation, which could otherwise go on making your condition worse. You must take this medicine regularly to get the maximum benefit from it. PREDNISOLONE SOLUBLE TABLETS CAN BE USED: • to treat breathing difficulties associated with asthma; • to treat severe allergic reactions; • to treat illnesses which cause inflamma Read the complete document
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Prednisolone 5mg Soluble Tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains 5mg prednisolone as the sodium phosphate ester. Excipient with known effect Each tablet contains 1.2mmol (28.2mg) sodium. For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Soluble Tablet Pink flat, round soluble tablets engraved with λ 5 and break marked on the same side. The tablet can be divided into equal doses. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Prednisolone 5mg Soluble Tablets are indicated in adults and children. A wide variety of diseases may sometimes require corticosteroid therapy. Some of the principal indications are: • bronchial asthma, severe hypersensitivity reactions, anaphylaxis; • rheumatoid arthritis, systemic lupus erythematosus, dermatomyositis, mixed connective tissue disease (excluding systemic sclerosis), polyarteritis nodosa; • inflammatory skin disorders, including pemphigus vulgaris, bullous pemphigoid and pyoderma gangrenosum; • minimal change nephrotic syndrome, acute interstitial nephritis; • ulcerative colitis, Crohn's disease; sarcoidosis; • rheumatic carditis; • haemolytic anaemia (autoimmune), acute lymphoblastic and chronic lymphocytic leukaemia, malignant lymphoma, multiple myeloma, idiopathic thrombocytopenic purpura; • immunosuppression in transplantation. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology The lowest dosage that will produce an acceptable result should be used (see section 4.4); when it is possible to reduce the dosage, this must be accomplished by stages. During prolonged therapy any intercurrent illness, trauma or surgical procedure will require a temporary increase in dosage; if corticosteroids have been stopped following prolonged therapy they may need to be temporarily re-introduced. ADULTS: The dose used will depend upon the disease, its severity and the clinical response obtained. The following regimens are for guidance only. Divided dosa Read the complete document